Hanqi Yuan

机构：Chinese Academy of Medical Sciences & Peking Union Medical College · ORCID：0009-0003-8437-6725

发表论文 4 篇 · 总被引 19 次 · h-index 2

代表论文

• Patients with non‑small cell lung cancer with the exon 21 L858R mutation: From distinct mechanisms to epidermal growth factor receptor tyrosine kinase inhibitor treatments (Review) (2024 · Oncology Letters · 被引 16)
• First‐Line Immune‐Combination Therapy for Driver Gene‐Negative NSCLC With Brain Metastases: Real‐World Outcomes (2025 · Thoracic Cancer · 被引 2)
• A Real‐World Study: Therapeutic Outcomes of ROS1 ‐Positive Advanced NSCLC (2025 · Thoracic Cancer · 被引 1)
• A random forest model to predict the efficacy of anti-PD-1/PD-L1 monoclonal antibody in lung adenocarcinoma. (2024 · Journal of Clinical Oncology)